Navigation Links
CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
Date:7/29/2008

sidy@curagen.com

Glenn Schulman, PharmD

Director of Medical Communications

gschulman@curagen.com

(888) 436-6642

CRGN-F

- FINANCIAL TABLES ATTACHED -

CURAGEN CORPORATION AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 2008 2007

(unaudited) (unaudited)

Collaboration revenue $1,152 $22 $1,174 $44

Operating expenses:

Research and development 3,635 10,904 9,006 22,406

General and administrative 1,443 3,049 3,159 7,063

Restructuring and other charges - 7,479 - 7,479

Total operating expenses 5,078 21,432 12,165 36,948

Gain on sale of intangible asset 36,397 - 36,397 -

Income (loss) from operations 32,471 (21,410) 25,406 (36,904)

Interest income 659 1,046 1,730 2,199

Interest expense (451) (1,271) (1,248) (2,899)

Gain on extinguishment of debt 6,991 - 6,991 -

Income (loss) from continuing

operations before income taxes 39,670 (21,635) 32,879 (37,604)

Income taxes (412) 50 (394) 110

Income (loss) from continuing

operations 39,258 (21,585) 32,485 (37,494)

Discontinued operations:

Loss from discontinued

operations
'/>"/>

SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. CuraGen Announces Top-Line Phase II Results on Velafermin
4. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
5. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
6. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
7. CuraGen Advances CR011-vcMMAE into Phase II
8. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
9. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
10. CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... 2013 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... commercialization of innovative therapies for the treatment of acute and ... , President and CEO, will present a corporate overview at ... Hotel in New York , NY.  The ... a.m. ET/6:30 a.m. PT. The presentation will be ...
(Date:5/16/2013)... Texas , May 16, 2013  ULURU Inc. (OTCQB: ... ended March 31, 2013 and provided a review of its ... the Company is confirming the previously communicated outlook for 2013: ... , Expanding the network of distribution partners to cover ... , Positioning Altrazeal ® to be marketed in ...
(Date:5/16/2013)... 16, 2013  A new survey of more than ... and vaginal atrophy (VVA) are either unaware of what ... dissatisfied with the therapies available. The REVIVE survey ( ... ews of Treatment Options for Menopausal Vulvar/ V aginal ... of VVA, including lack of knowledge, reluctance to discuss ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 3ULURU Inc. Reports First Quarter 2013 Financial Results 2ULURU Inc. Reports First Quarter 2013 Financial Results 3ULURU Inc. Reports First Quarter 2013 Financial Results 4ULURU Inc. Reports First Quarter 2013 Financial Results 5New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 2New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 3
(Date:5/18/2013)... May 18, 2013 The “Sleep Apnea ... Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal ... to 2017” analyzes and studies the major market drivers, ... Rest of the World. , Browse , ... 16 Figures , 318 pagesand ...
(Date:5/18/2013)... Adolescents, especially young males, who experiment with synthetic ... landing in emergency rooms across America. Recovery ... with a new treatment program for those addicted to ... the National Institute on Drug Abuse, synthetic marijuana has ... In 2012, 11 percent of high school seniors had ...
(Date:5/18/2013)... DF (PRWEB) May 18, 2013 The ... leading ayurvedic education institution in the West. Program is ... education. , Ayurveda is a healing modality practiced for ... ), it is considered that health begins when an ... profound understanding of their individual needs. Ayurveda aims to ...
(Date:5/18/2013)... Bay, CA (PRWEB) May 18, 2013 ... , has recently completed a stylish renovation that features ... advanced specialties. , From the ground up, this ... improved with fresh flooring, soothing colors and comfortable spa ... been installed, including an Apilus epilator machine. The ...
(Date:5/18/2013)... Losing weight remains to be the biggest ... of new weight loss products available in the market today, ... about this newest weight loss supplement prove that dieting and ... Garcinia Cambogia is a sub-tropical fruit that is shaped like ... can suppress a person’s appetite, while it effectively burns fat ...
Breaking Medicine News(10 mins):Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2
... upheld a ban on a teenager from wearing a so-called "purity ... ,Lydia Playfoot, 16, said she was "disappointed" by ... School in Horsham, West Sussex, denies infringing her human rights, saying ... faith and violates its uniform policy. ,"As a Christian ...
... of Illinois at Chicago have created a theoretical blueprint ... , ,Scientists say the propeller opens the ... and out of cells. ,, ,Petr Krl, ... co-workers, used classical molecular dynamics simulations to learn how ...
... technological innovations have transformed the lives of the hard ... the deaf said Tuesday. ,"Technology is important ... webcams, email, SMS and chat systems," said Amparo Minguet, ... in the eastern city of Valencia. ,Minguet ...
... Severe organ shortage plagues many countries across the world. Perhaps ... donor unless they explicitly refuse to consent , Sir Liam ... has noted that current severe shortage only leads to the ... ,According to figures, 70 per cent of people ...
... of the American Academy of Neurology, children who have had ... grades in foreign language are the most affected and girls ... , Researchers say this is the first time ... been reported. ,These results will help us identify ...
... Administration approved a new birth control pill, Lybrel. It ... already in the market , but overrides them with one ... ,Lybrel is landing on pharmacy shelves this month. ... altogether. ,Already the first few volleys in this ...
Cached Medicine News:Health News:New Technology Transforming Life for the Deaf 2Health News:Treat Every Patient as a Potential Organ Donor, British Health Official Says 2Health News:Brain Tumor Children Poor Performance in Schools 2Health News:The Queen Of All Contraceptives Released 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: